Zimmer Biomet Details First Post-Merger Financials

Indiana's medical device industry is widely known as one of the strongest in the world.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting a loss of $158 million, compared to a profit of $176.5 million during the same period in the previous year. This is the first earnings report released by the company that resulted from the around $14 billion merger of Zimmer Holdings Inc. and Biomet Inc.

The company still expects to achieve $350 million in synergies three years after the closing of the merger.

Chief Executive Officer David Dvorak says "with a broad and diversified musculoskeletal portfolio, Zimmer Biomet is well positioned to reach new heights of commercial and operational excellence, and to accelerate the pace of our innovation for the evolving healthcare landscape."

You can view more details about the earnings report by clicking here.